These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 17571902

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Terminal sugars of Fc glycans influence antibody effector functions of IgGs.
    Raju TS.
    Curr Opin Immunol; 2008 Aug; 20(4):471-8. PubMed ID: 18606225
    [Abstract] [Full Text] [Related]

  • 4. Site-specific N-glycosylation of chicken serum IgG.
    Suzuki N, Lee YC.
    Glycobiology; 2004 Mar; 14(3):275-92. PubMed ID: 14693911
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Production and molecular characterization of clinical phase i anti-melanoma mouse IgG3 monoclonal antibody R24.
    Kemminer SE, Conradt HS, Nimtz M, Sagi D, Peter-Katalinić J, Diekmann O, Drmić I, Müthing J.
    Biotechnol Prog; 2001 Mar; 17(5):809-21. PubMed ID: 11587568
    [Abstract] [Full Text] [Related]

  • 9. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
    Hodoniczky J, Zheng YZ, James DC.
    Biotechnol Prog; 2005 Mar; 21(6):1644-52. PubMed ID: 16321047
    [Abstract] [Full Text] [Related]

  • 10. Global and site-specific detection of human integrin alpha 5 beta 1 glycosylation using tandem mass spectrometry and the StrOligo algorithm.
    Ethier M, Krokhin O, Ens W, Standing KG, Wilkins JA, Perreault H.
    Rapid Commun Mass Spectrom; 2005 Mar; 19(5):721-7. PubMed ID: 15702487
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. N-glycans of recombinant human acid alpha-glucosidase expressed in the milk of transgenic rabbits.
    Jongen SP, Gerwig GJ, Leeflang BR, Koles K, Mannesse ML, van Berkel PH, Pieper FR, Kroos MA, Reuser AJ, Zhou Q, Jin X, Zhang K, Edmunds T, Kamerling JP.
    Glycobiology; 2007 Jun; 17(6):600-19. PubMed ID: 17293352
    [Abstract] [Full Text] [Related]

  • 13. Site-specific N-glycan characterization of human complement factor H.
    Fenaille F, Le Mignon M, Groseil C, Ramon C, Riandé S, Siret L, Bihoreau N.
    Glycobiology; 2007 Sep; 17(9):932-44. PubMed ID: 17591618
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. N-glycan structures and N-glycosylation sites of mouse soluble intercellular adhesion molecule-1 revealed by MALDI-TOF and FTICR mass spectrometry.
    Otto VI, Damoc E, Cueni LN, Schürpf T, Frei R, Ali S, Callewaert N, Moise A, Leary JA, Folkers G, Przybylski M.
    Glycobiology; 2006 Nov; 16(11):1033-44. PubMed ID: 16877748
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous beta1, 4-N-acetylglucosaminyltransferase III and Golgi alpha-mannosidase II.
    Ferrara C, Brünker P, Suter T, Moser S, Püntener U, Umaña P.
    Biotechnol Bioeng; 2006 Apr 05; 93(5):851-61. PubMed ID: 16435400
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Glycosylation pattern of humanized IgG-like bispecific antibody produced by recombinant CHO cells.
    Kim WD, Tokunaga M, Ozaki H, Ishibashi T, Honda K, Kajiura H, Fujiyama K, Asano R, Kumagai I, Omasa T, Ohtake H.
    Appl Microbiol Biotechnol; 2010 Jan 05; 85(3):535-42. PubMed ID: 19652963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.